SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Celera Genomics (CRA) -- Ignore unavailable to you. Want to Upgrade?

To: gao seng who wrote (373)5/16/2000 11:08:00 AM
From: gao seng  Read Replies (1) | Respond to of 746
 
re: LA Times article - Another Microsoft - Celera similarity?

from a Slashdot discussion forum on the genome at
slashdot.org

Remember, Microsoft's first product (Basic for
the Altair, I think) was supposedly largely
developed and tested on an emulator running on
a government-funded computer at Harvard.



To: gao seng who wrote (373)5/16/2000 12:05:00 PM
From: allen menglin chen  Read Replies (1) | Respond to of 746
 
Thanks for your 2 CRA links today. All I care is CRA has $20 cash/share after it early March SPO -- increase the outstanding shares by ~10% @ 225/sh. And good news on the way by early June.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News